Overview

An Study of Efficacy and Safety of Clevudine

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Randomized, double blind parallel group, positive control, multi-center trial. Patients will be randomized at 1:1 ratio in group A or group B
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Adefovir
Adefovir dipivoxil
Clevudine